FDA Device Intelligence
Home › Promisemed Medical Devices Inc. › Verifine

Verifine

Promisemed Medical Devices Inc. · Model ISY-8102812-100 · UDI-DI 00850062218239

FMF
10
510(k) clearances
53,081
Adverse events (66 deaths)
305
Recalls
545
Facilities

Description

The proposed device Insulin Syringe, a sterile device consisting of a calibrated barrel with plunger, is intended to be used to administer an injection of insulin to a patient subcutaneously. A non-retractable integrated needle is included. The syringe is made of plastic and silicone materials and allowing smooth plunger movement. This is a single-use device. The device is the same as K193273. The purpose of the submission is to add OTC labeling.

Recalls

DateFirmReason
2026-04-28Mentor Texas LPA single lot of expired syringes were distributed due to a distribution system control failure.
2026-04-21ARROW INTERNATIONAL, LLCLidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited repo
2026-02-27Cardinal Health 200, LLCThe outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages
2026-01-27Becton Dickinson & CompanyDuring the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.
2025-05-23Integra LifeSciences Corp. (NeuroSciences)Lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-12BD SWITZERLAND SARLSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the
2025-05-12BD SWITZERLAND SARLSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.